TREMOR
本態性振戦は、家族性振戦、特発性振戦、良性振戦とも呼ばれ、患者さんご自身では制御不能なふるえを引き起こすため、日々の生活に大きな影響を与えます。薬物療法で効果が得られない場合、次のステップとして外科的治療が必要になる場合があります。集束超音波はメスを使わず、さらに合併症のリスクを最小限に抑えながらふるえを低減することが期待できる治療法です。
治療はMRIで温度変化をモニタリングしながら、ふるえの原因と考えられる脳内の小さな部位に超音波を正確に集中させます。最初に低強度の超音波周波を照射しますが、その際、患者さんには感覚や副作用の有無を医師に伝えていただきます。その後、医師が患者さん毎に照射部位を微調整していきます。少しずつエネルギーを上げていき、限局的な治療用照射野を作ります十分な治療効果が得られた時点で治療を終了します。
これまでに多くの患者さんで、治療後、すぐの手のふるえの軽減改善が確認されています。これまでに世界中で3,500人以上の患者さんが治療を受けて、今も増え続けています。
安全性に関する情報については、添付文書をご参照ください。
Find a Treatment Center for ETOr contact Insightec Educators at 1-800-704-6797
Treatment Stages
What is Focused Ultrasound treatment?
Focused Ultrasound is a treatment for essential tremor where sound waves are focused through the skull to a target without the need for incisions, brain implants or radiation. It is based on high intensity focused ultrasound guided by MR imaging.
Treatment Stages
Before treatment
On treatment day, your head will be shaved so that nothing will interfere with the ultrasound beams. Your hair will naturally grow back after the treatment. After local numbing medication is applied, a frame will be secured to your head and an elastic cap is placed to seal the helmet, where water is circulated.
Treatment Stages
During and After Treatment
During the treatment, you will lie down on the treatment bed inside the MRI scanner. The medical team will be in the control room and you will be conscious and able to communicate with them. Your head will be positioned in the focused ultrasound helmet which is filled with water, and you will have a blanket to keep you warm.
Treatment Stages
Risks and Side Effects
Important Safety Information
You should have a detailed conversation with your physician regarding the risks and benefits of treatment options prior to treatment.
治療の原理と
効果について
メスを使わず、回復時間も短い集束超音波治療。安全かつ効果的に本態性振戦の手のふるえの軽減が期待できるこの治療法をご紹介します。
- メスを使わず底侵襲な治療
感染症のリスクがほとんどありません。
- 手のふるえの症状を軽減
長期間にわたる効果の持続が期待できます。
- 1回の治療
1回の治療で症状の軽減が期待できます。
- 患者さん毎の最適な治療
1ミリ以下の単位で照射位置を設定可能です。
- 最小限の合併症リスク
安全で効果的な治療法です。
- Safe and Effective
With minimal side effects.1
Carol’s Documentary
Carol Klein, a lifelong schoolteacher, came to a point in her life where she decided it was time to take control of her shaking hands. She was not going to let Essential Tremor stop her from enjoying life. View Insightec’s documentary about Carol’s incredible journey.
Testimonials may not be representative of all treatment outcomes.
How Is Essential Tremor treated?
From general information about Focused Ultrasound to what a typical treatment day looks like, we are here to help guide you on your journey to tremor treatment. Below we have answered the most frequently asked questions from our patient and caregiver community.
- What is Focused Ultrasound?
How long has this Treatment been approved by the FDA?
Almost five years. The FDA approved the Exablate Neuro device for treating Essential Tremor with Focused Ultrasound at the end of 2016.
How many patients have been treated?
More than 3,500 Essential Tremor patients have been treated with Insightec’s Focused Ultrasound.
- Insurance Coverage
What is the five-character CPT code for the Focused Ultrasound procedure?
The current CPT code for MRgFUS is 0398T; Magnetic resonance image guided high intensity focused ultrasound (MRgFUS), stereotactic ablation lesion, intracranial for movement disorder including stereotactic navigation and frame placement when performed. We are providing this code for general information purposes only; each provider is responsible for its own coding and billing activities.
What is the cost of the procedure if it’s not covered by my insurance?
The cost for cash paying patients is set by the treatment center. For a complete list of treatment centers and their contact information, click on the link below.
https://insightec.com/treatment-centers/In which states is there Medicare Coverage for Focused Ultrasound treatment for Essential Tremor?
MR-guided focused ultrasound treatment for medication-refractory Essential Tremor is a Medicare covered benefit in all 50 states.
Is Focused Ultrasound covered under Medicare Part A, Medicare Part B, or a supplemental Medicare plan?
Magnetic Resonance guided Focused Ultrasound (MRgFUS), for the treatment of essential tremor is covered under Medicare Part B.
How do I know if my private health insurance plan covers the treatment?
Contact your health plan’s Member Service department by calling the phone number listed on the back of your insurance ID card. Ask whether or not MR-guided Focused Ultrasound for treating essential tremor (CPT code 0398T) is a covered benefit in an outpatient setting based on your health plan.
Do private health insurance plans cover the treatment?
Aetna’s coverage of focused ultrasound treatment of essential tremor (ET) that does not respond to medications applies across the country. Also, a total of 39 Independent Blue Cross Blue Shield Association plans have adopted the National Medical Policy for coverage of MR-guided focused ultrasound to treat medication-refractory Essential Tremor.
Can I travel to other states to receive treatment if my state is not covered by Blue Cross Blue Shield?
It is our understanding that under the Blue Card Network, patients traveling outside of their home state for treatment at a facility providing MRgFUS would be subject to their home plan coverage decision. We recommend confirming coverage with your health plan and the treatment center prior to treatment.
- Am I a Candidate for Focused Ultrasound?
Should I try medications first?
The first line of treatment for Essential Tremor is medications. If you have a confirmed diagnosis of essential tremor and prescribed medications (such as propranolol or primidone) have not provided satisfactory tremor improvement, you may be a candidate for Focused Ultrasound.
If I have tremor in both hands, do I need two treatments, one for each hand?
The Focused Ultrasound treatment is FDA approved for unilateral treatment – treating one side, usually the dominant hand.
- Treatment Options for Essential Tremor
How Is Essential Tremor treated?
Mild essential tremor may not require treatment. However, if essential tremor interferes with your ability to function or if you are uncomfortable in social situations, there are treatments that may improve symptoms.
Treatments may include medications (as the first line of treatment), the Focused Ultrasound treatment or surgical options. Please keep in mind that only a physician can advise you on the risks, benefits, and alternatives for treating your condition.What is Focused Ultrasound?
Focused Ultrasound is a treatment option where sound waves can be focused through the skull to target a very specific location deep within the brain without the need for incisions or holes in the skull. This is the same target used for years with other more invasive surgery, but now can be reached without incisions or anesthesia.
Focused Ultrasound (FUS) waves converge at a focal point to create a small lesion in the targeted area of the brain.
The MRI system is the eyes of the treatment, enabling the physician to identify and target the treatment area with high precision as well as monitor the temperature during treatment.
Risks associated with any thalamotomy, include transient and/or permanent sensory numbness, imbalance, and/or gait disturbance. These events are generally transient and mild or moderate in severity. Other risks and adverse events associated with the treatment include brief sonication-related pain, brief sonication-related dizziness, nausea and potential for deep vein thrombosis associated with lengthy time on the treatment bed.
Focused Ultrasound may be a treatment option for patients with medication-refractory essential tremor who are at least 22 years old.
What are some medications that can reduce the severity of the tremor in some patients?
Propranolol (Inderal®)is the only medication approved by the FDA for the treatment of essential tremor, but it is primarily used for treating high blood pressure
Primidone (Mysoline®) is an anti-seizure medicine
Anti-anxiety medications may be useful in patients who do not respond to other medications or who have associated anxiety
These medications can cause side effects, and you should ask your physician to learn more.
What is Deep Brain Stimulation (DBS) Surgery?
Today, the most common approach to treating essential tremor when medications no longer help is deep brain stimulation (DBS). This form of treatment consists of two staged surgeries to implant an electrode deep into the brain, tunnel the wires under the skin down the neck and implant a pulse generator below the skin near the collar bone. This treatment targets the same location as the Neuravive focused ultrasound treatment. DBS requires follow up throughout the patient’s life for adjustment of stimulation and eventual replacement of generator(s) to replace batteries. As an invasive surgery to access the brain, DBS poses risks typically associated with surgery, such as infection and bleeding in the brain, and with implantation of chronic hardware in the body, such as infection and potential equipment malfunction.
What is Thalamotomy?
Conventional, surgical thalamotomy is an invasive procedure where the target ( the Vim of the thalamus) is surgically destroyed (ablated). Neurosurgeons use specialized probes inserted deep into the brain to precisely locate the treatment target. Like DBS surgery and the Neuravive procedure, the patient is usually awake, and the area on the scalp where the surgical tools are inserted is numbed with an anesthetic. Different methods can be used to kill the brain cells, including radio-frequency heating or cooling with a special probe. As an invasive surgery to access the brain, thalamotomies pose risks inherent in any surgery, such as infection and bleeding in the brain.
Additional information about these treatment options is available at https://www.
essentialtremor.org/ and https://www.treatments/ webmd.com/brain/essential-tremor-stereotactic-thalamotomy .What is Stereotactic Radiosurgery?
Stereotactic radiosurgery emits powerful, highly accurate gamma radiation beams to target the cells of the ventral intermediate nucleus (VIM) in the thalamus in order to destroy overactive cells that cause tremor. Surrounding areas remain untouched as 192 beams of focused radiation are combined with a low dose of radiation.
- During and After Treatment
Why do I have to be awake during the treatment?
Your feedback is necessary as you will be asked to do tasks such as drawing spirals. This is so the physician can evaluate the improvement of your tremor and identify any potential side effects that you may be experiencing during the treatment.
How long do I have to stay for the treatment during and after?
The average treatment time is 2.5 hours. The treatment is usually performed on an outpatient basis; however the treating physician will decide when you can return home.
Will my tremor return?
There is the possibility that your hand tremor may return months or even years after Focused Ultrasound treatment, or that the tremor may not improve at all. And while the treatment may improve your tremor, it’s important to understand that it does not treat the underlying disease nor prevent its progression.
How soon can I return to work after treatment?
That depends on the type of work you do and how you feel. Please consult with your physician.
- Risks and Side Effects
What side effects can I expect during the treatment?
You should have a detailed conversation with your physician regarding risks and benefits of treatment. Insightec-sponsored clinical studies have shown that the most common side effects are imbalance/gait disturbance, numbness/tingling, and headache/head pain. Additional infrequent events include dizziness, taste disturbance, slurred speech, fatigue, and vomiting.
What side effects can I expect after the treatment?
There is a small risk that you could develop temporary or permanent muscle weakness, unsteadiness when walking, sensory loss, or numbness or tingling in your fingers or elsewhere in your body.
Clinical Study
Overview
Insightec sponsored a clinical trial of the Exablate® Neuro platform to evaluate focused ultrasound to treat patients with medication-refractory Essential Tremor.
The 3-year data demonstrates a durable reduction in hand tremor and improvement in quality of life in subjects who received focused ultrasound for medication-refractory essential tremor.
Efficacy results
3 year follow up pivotal study of focused ultrasound for Essential Tremor¹ (See chart)
Percentages represent tremor improvement over baseline.
1 Pre-Market Approval (PMA) P150038
Safety results
Insightec-sponsored clinical studies have shown that the most common adverse events experienced after treatment included: imbalance/gait disturbance (26%), numbness/tingling (33%), and headache/head pain (51%). Most of these events were classified as mild or moderate, and 48% of all adverse events resolved on their own within 30 days.
Adverse events that persisted at 3 years were all mild or moderate and included: numbness/tingling (9%), imbalance (4%), unsteadiness (4%), gait disturbance (2%), and musculoskeletal weakness (2%). Additional infrequent events include dizziness, taste disturbance, slurred speech, fatigue and vomiting.
The number in parenthesis is the percentage of active subjects experiencing these adverse events.
For additional safety information, please refer to Pre-Market Approval (PMA) P150038
Clinical Study – Second Side Trial
Overview
Insightec sponsored a clinical study of the Exablate® Neuro platform to evaluate focused ultrasound to unilaterally treat the contralateral side for patients with medication-refractory Essential Tremor who had already received an Exablate focused ultrasound index procedure at least 9 months prior.
The 6-month data demonstrates a durable reduction in hand tremor and improvement in quality of life in subjects who received a unilateral focused ultrasound for medication-refractory essential tremor on their contralateral side from the index focus ultrasound thalamotomy.
Efficacy results
6-month follow up study of focused ultrasound for Essential Tremor2 (See chart)Percentages represent tremor improvement over baseline.
2 Pre-Market Approval (PMA) P150038 – S022
Safety results
The most common adverse events, or complications, reported by subjects in Insightec-sponsored clinical studies after treatment included: Ataxia (24% of study patients), numbness/tingling (33%), dysarthria (29% of subjects), dysgeusia (14% of patients), imbalance (10% of patients), unsteadiness (10% of patients), gait disturbance (10% of patients), dysphagia (10% of patients), hypogeusia (10% of patients).
98% of these events were classified as mild (85%) or moderate (13%), and 51% of all adverse events resolved on their own within 6 months. Additional infrequent (<5%) events dysmetria, fatigue, weakness, decrease in synchronicity, dizziness, dry mouth, hypoesthesia, intermittent diplopia, sialorrhea, voice change, facial droop, headache, and UTI.
They were no device related adverse events.
Only one related serious event occurred – a urinary tract infection following use of catheter during the procedure.
For additional safety information for Staged Unilateral Treatment of the Contralateral Side, please refer to Pre-Market Approval P150038 Supplement S022. Again, you should discuss in detail the risks, benefits and treatment options with your physician prior to treatment.
Safety Information
Important Safety Information
You should have a detailed conversation with your physician regarding complications, also known as adverse events, that you may experience.
Insightec-sponsored clinical studies have shown that the most common adverse events experienced after treatment included: 1) imbalance/gait disturbance (26%), 2) numbness/tingling (33%), and 3) headache/head pain (51%). Most of these events were classified as mild or moderate, and 48% of all adverse events resolved on their own within 30 days.
Adverse events that persisted at 3 years were all mild or moderate and included: numbness/tingling (9%), imbalance (4%), unsteadiness (4%), gait disturbance (2%), and musculoskeletal weakness (2%). Additional infrequent events include dizziness, taste disturbance, slurred speech, fatigue and vomiting.
The number in parenthesis is the percentage of active subjects experiencing these adverse events.
For details of the clinical study methods and results, download Clinical Study Results. For additional safety information, please refer to Pre-Market Approval (PMA) P150038
Regulatory Approval
FDA Approved
The Exablate Neuro is intended for use in the unilateral Thalamotomy treatment of idiopathic Essential Tremor patients with medication-refractory tremor. Patients must be at least age 22. The designated area in the brain responsible for the movement disorder symptoms (ventralis intermedius) must be identified and accessible for targeted thermal ablation by the Exablate device.
Click here to view the regulatory approvals of Insightec products by country.
Advocacy
Partners
From working diligently toward medical advances, to providing holistic community support, Advocacy groups like the ones below champion both patients and the healthcare professionals treating them.
Focused Ultrasound Foundation (FUSF)
Focused Ultrasound Foundation. FUSF was created to improve the lives of millions of people with serious medical disorders by accelerating the development and adoption of focused ultrasound.
Visit WebsiteInternational Essential Tremor Foundation (IETF)
“Your voice for Essential Tremor”
Visit Website
The International Essential Tremor Foundation. IETF is a non-profit organization that provides hope to the essential tremor (ET) community worldwide through awareness, education, support, and research.HOPENET
HopeNET is a non-profit organization whose purpose is to advocate for, educate, and support those with Essential Tremor.
Visit Website